Adiponectin Contributes to the Inflammatory Milieu in Hidradenitis Suppurativa.
adiponectin
cytokines
hidradenitis suppurativa
immune system
inflammation
Journal
Dermatology practical & conceptual
ISSN: 2160-9381
Titre abrégé: Dermatol Pract Concept
Pays: Austria
ID NLM: 101585990
Informations de publication
Date de publication:
Nov 2022
Nov 2022
Historique:
accepted:
08
03
2022
entrez:
19
12
2022
pubmed:
20
12
2022
medline:
20
12
2022
Statut:
epublish
Résumé
Hidradenitis suppurativa (HS) is a severe chronic skin disease. Although the pathogenesis remains unclear, at the basis of HS there is an enhancement of the immune and inflammatory response together with a susceptibility to environmental factors. Cytokine dysregulation is crucial in HS severity and progression. The aim of this study was to analyze serum levels of different cytokines focusing on adiponectin concentration and its oligomers in HS patients compared to both obese and healthy subjects. The concentrations of adiponectin and cytokines were measured using enzyme-linked immunosorbent assay (ELISA); the oligomeric distribution of adiponectin (low molecular weight (LMW), medium molecular weight (MMW) and high molecular weight (HMW) oligomers)was evaluated through Western Blotting analysis. Total adiponectin is statistically higher in HS patients compared to matched controls and obese subjects. Interestingly, Adiponectin oligomerization state is altered in HS, with an increase of HMW oligomers. Serum levels of PDGF-BB, IL-1β, IL-5, Il-6, IL12, IL13, IL15, IL-17, GMCSF, INFγ, VEGF and MCP-1 are statistically higher while IL-1ra and RANTES levels are statistically lower in HS patients compared to healthy controls. Interestingly, adiponectin positively correlates with PDGF-BB, and IL-13. Our data confirmed that the complex network that links metabolism to immune homeostasis is dysregulated in HS and that adiponectin and its HMW oligomers are actively involved in this disease. In addition, the correlation between adiponectin and PDGF-BB, and IL-13 extends the role of this adipokine in modulation of the immune response, in particular regulating the innate immune system rather that the adaptive one. Further researches are needed to clarify the complex inflammatory milieu that characterizes HS syndrome.
Identifiants
pubmed: 36534576
doi: 10.5826/dpc.1204a157
pii: dp1204a157
pmc: PMC9681230
doi:
Types de publication
Journal Article
Langues
eng
Pagination
e2022157Informations de copyright
©2022 Nigro et al.
Déclaration de conflit d'intérêts
Competing interests: None.
Références
Br J Dermatol. 2017 Nov;177(5):1385-1393
pubmed: 28256718
Cytokine. 2017 Jun;94:8-13
pubmed: 28385328
Ann Biol Clin (Paris). 2020 Jun 1;78(3):243-252
pubmed: 32540813
Clin Chim Acta. 2007 May 1;380(1-2):24-30
pubmed: 17343838
F1000Res. 2020 Aug 26;9:
pubmed: 32884675
J Eur Acad Dermatol Venereol. 2021 Jan;35(1):50-61
pubmed: 32460374
J Mol Cell Biol. 2016 Apr;8(2):93-100
pubmed: 26993047
PLoS One. 2015 Jun 19;10(6):e0130522
pubmed: 26091259
Front Immunol. 2018 Dec 14;9:2965
pubmed: 30619323
Arch Dermatol Res. 2020 Oct;312(8):595-600
pubmed: 31786710
Rev Endocr Metab Disord. 2016 Sep;17(3):305-317
pubmed: 27554109
FEBS Lett. 2008 May 28;582(12):1719-24
pubmed: 18455514
Br J Dermatol. 2016 Mar;174(3):514-21
pubmed: 26436522
Ther Adv Musculoskelet Dis. 2019 Dec 30;11:1759720X19895488
pubmed: 31908656
Br J Dermatol. 2018 Mar;178(3):792-793
pubmed: 28834543
Int J Dermatol. 2020 Apr;59(4):406-411
pubmed: 31663126
Circulation. 2002 Jun 18;105(24):2893-8
pubmed: 12070119
Exp Dermatol. 2018 Feb;27(2):172-177
pubmed: 29222824
Expert Rev Clin Immunol. 2016 Dec;12(12):1299-1308
pubmed: 27322922
Biomed Res Int. 2014;2014:658913
pubmed: 25110685
Eur J Neurol. 2019 Feb;26(2):348-355
pubmed: 30300462
J Am Acad Dermatol. 2011 Oct;65(4):790-798
pubmed: 21641076
JID Innov. 2021 Jan 12;1(1):100001
pubmed: 34909706
Neurol Neurochir Pol. 2012 Jan-Feb;46(1):22-8
pubmed: 22426759
Clin Exp Immunol. 2020 Aug;201(2):121-134
pubmed: 32379344
Immunotargets Ther. 2016 May 23;5:47-56
pubmed: 27529061
Int J Mol Sci. 2020 Feb 12;21(4):
pubmed: 32059381
J Am Acad Dermatol. 2021 May;84(5):1405-1406
pubmed: 32860911
Nutrients. 2019 Sep 12;11(9):
pubmed: 31547312
F1000Res. 2018 Dec 11;7:1923
pubmed: 31281635
Anticancer Res. 2020 Jul;40(7):3751-3757
pubmed: 32620614
World J Biol Chem. 2017 May 26;8(2):120-128
pubmed: 28588755
Mediators Inflamm. 2017;2017:2450401
pubmed: 28769536
Front Immunol. 2017 Jul 31;8:895
pubmed: 28824624
Cell Rep. 2014 Dec 11;9(5):1574-1583
pubmed: 25466256
Nat Rev Dis Primers. 2020 Mar 12;6(1):18
pubmed: 32165620